Cytokeratin 19 Immunohistochemistry Antibody

 Cytokeratin 19 (Immunohistochemistry) Antibody

Detection of Epithelial Cell Marker in Carcinomas

The Cytokeratin 19 (CK19) antibody, developed by Talent Biomedical, is a highly specific immunohistochemistry (IHC)
reagent used for the detection of intermediate filament proteins in epithelial cells.
CK19 is a valuable epithelial marker widely expressed in various tissues and has significant diagnostic importance in papillary thyroid carcinoma
, colorectal adenocarcinoma, breast carcinoma, and lung carcinoma.

Overexpression of CK19 is frequently observed in malignant epithelial tumors, making it a useful biomarker for identifying the
origin of metastatic carcinomas and distinguishing epithelial tumors from mesenchymal lesions.

🌐 Fardad Azma Rad Co.

Fardad Azma Rad Co. is the exclusive representative of Talent Biomedical Technology Co., Ltd. (China) in Iran and the authorized distributor of professional immunohistochemistry (IHC) antibodies, including Cytokeratin 19 (CK19).
With a focus on diagnostic precision, product reliability, and international quality standards,
Fardad Azma Rad supplies advanced IHC solutions to pathology and molecular diagnostic laboratories across Iran.

🔬 Features and Benefits

• Highly specific marker for epithelial cells and epithelial-origin tumors

• Cytoplasmic brown staining pattern with high sensitivity

• Ideal for detecting lymph node metastases and papillary thyroid carcinoma

• Fully compatible with FFPE tissue sections and DAB detection systems

• Certified CE-IVD and manufactured under strict international standards

💡 Diagnostic Applications

• Detection of Papillary Thyroid Carcinoma

• Identification of Colorectal Adenocarcinoma

• Evaluation of metastatic tumor origin

• Differentiation between epithelial and mesenchymal tumors

“Download Brochure”